Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease

Author(s)

• Garber, Alan M.
• United States. Congress. Office of Technology Assessment

Bibliographic Information

Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease

[prepared by Alan M. Garber ... et al.]

（Background paper / United States. Office of Technology Assessment）

Office of Technology Assessment , For sale by the Supt. of Docs., U.S. G.P.O., [1992]

Note

"October 1992"--P. [4] of cover

"OTA-BP-H-104"--P. [4] of cover

Includes bibliographical references (p. 29-34)

Details

• NCID: BA53406801
• ISBN:
  • 0160381290
• LCCN: 93123698
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Washington, D.C.,Washington, D.C.
• Pages/Volumes: vii, 34 p.
• Size: 26 cm
• Classification:
  • LCC : RC632.G36
  • DC20 : 616.3/9
• Subject Headings:
  • LCSH : Gaucher's disease -- Treatment -- United States
  • LCSH : Orphan drugs -- United States
  • LCSH : Pharmaceutical policy -- United States
• Parent Bibliography ID:
  • BA26155913